Key result
Pediatric lipid screening has low uptake due to a lack of compelling evidence, disagreement with clinical recommendations, and concerns about overdiagnosis and overtreatment.
Answers are grounded in this paper and cite their sources.
Highlights skepticism and concerns for overdiagnosis as key factors driving low adherence to pediatric lipid screening recommendations.
This Viewpoint discusses factors that play a role in the low rate of lipid screening in children, including a lack of compelling evidence, disagreement with recommendations, and concerns for overdiagnosis and overtreatment.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2024) studied this question. Pediatric lipid screening has low uptake due to a lack of compelling evidence, disagreement with clinical recommendations, and concerns about overdiagnosis and overtreatment.
Synapse has enriched 10 related papers. Consider them for comparative context: